TC BioPharm (Holdings) plc Warrants
TCBPW
TCBPW was delisted on the 21st of March, 2025.
6 hedge funds and large institutions have $14.1K invested in TC BioPharm (Holdings) plc Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
42% more capital invested
Capital invested by funds: $9.94K → $14.1K (+$4.18K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$287 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$504 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$257 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KC
1
Kepos Capital
New York
| $9K | – | – | – |
|
|
NCM
2
Nantahala Capital Management
New Canaan,
Connecticut
| $4.28K | – | – | – |
|
|
CAG
3
Csenge Advisory Group
Clearwater,
Florida
| $472 | +$287 | +18,862 | New |
|
|
ACM
4
Altium Capital Management
New York
| $343 | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $21 | +$17 | +1,147 | +3,374% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $1 | -$5 | -311 | -81% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$504 | -37,609 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$257 | -19,178 | Closed |
|
TCBPW Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q3 2024, worth a combined $14.1K — up 42% from $9.94K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TCBPW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Csenge Advisory Group, opening a new position worth an estimated $287. The largest seller was Susquehanna International Group, exiting entirely with an estimated $504 sold.
- 6 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q3 2024, down from 8 in Q2 2024.
- Funds reported $14.1K of TC BioPharm (Holdings) plc Warrants stock for Q3 2024, up 42% quarter-over-quarter.
- 1 fund opened new TC BioPharm (Holdings) plc Warrants positions in Q3 2024 and 3 closed out, a net change of -2 holders.
- The largest TC BioPharm (Holdings) plc Warrants buyer in Q3 2024 was Csenge Advisory Group, an estimated $287 added.
- The largest TC BioPharm (Holdings) plc Warrants seller in Q3 2024 was Susquehanna International Group, an estimated $504 sold.
Based on aggregated 13F filings for Q3 2024.